Literature DB >> 26550359

Association between clusterin polymorphisms and esophageal squamous cell carcinoma risk in Han Chinese population.

Kun Li1, Jian Wang1, Zhen-Bin Ma1, Guang-Hong Guo2.   

Abstract

Genetic susceptibility plays an essential role in an individual's risk of esophageal squamous cell carcinoma (ESCC). The aim of this study is to investigate the associations between clusterin (CLU) gene polymorphisms and ESCC risk. We undertook a case-control study to analyze three CLU polymorphisms (gene rs9331888 C>G, rs17466684 A>G and rs1532278 T>C) in an Han Chinese population, by extraction of genomic DNA from the peripheral blood of 642 patients with ESCC and 658 control participants, and performed CLU genotyping using DNA sequencing. The obtained results indicated that overall, no statistically significant association was observed in rs17466684 and rs1532278. However, gene rs9331888 C>G genotype was at increased risk of ESCCs (P=0.037; odds ratio (OR)=1.089, 95% CI: 1.006-1.175). Moreover, rs9331888 G/G genotype ESCCs were more significantly common in patients with tumor size of >5 cm than T allele ESCC and in cases of poor differentiation and lower advanced pathological stage. In conclusion, polymorphism in rs9331888 C>G was observed to be associated with susceptibility of ESCC. Nevertheless, further investigation with a larger sample size is needed to support our results.

Entities:  

Keywords:  Allele; CLU; esophageal squamous cell carcinoma; polymorphism

Year:  2015        PMID: 26550359      PMCID: PMC4613044     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  37 in total

1.  Allelic variation in human gene expression.

Authors:  Hai Yan; Weishi Yuan; Victor E Velculescu; Bert Vogelstein; Kenneth W Kinzler
Journal:  Science       Date:  2002-08-16       Impact factor: 47.728

2.  Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension.

Authors:  Toshifumi Kurahashi; Mototsugu Muramaki; Kazuki Yamanaka; Isao Hara; Hideaki Miyake
Journal:  BJU Int       Date:  2005-10       Impact factor: 5.588

Review 3.  Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.

Authors:  B Shannan; M Seifert; K Leskov; J Willis; D Boothman; W Tilgen; J Reichrath
Journal:  Cell Death Differ       Date:  2006-01       Impact factor: 15.828

4.  Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression.

Authors:  Dan Xie; Jonathan-S-T Sham; Wei-Fen Zeng; Li-Hong Che; Meng Zhang; Hui-Xi Wu; Han-Liang Lin; Jian-Ming Wen; Sze-Hang Lau; Liang Hu; Xin-Yuan Guan
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

5.  A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma.

Authors:  Xiaojiao Zhang; Jinyu Wei; Liqing Zhou; Changchun Zhou; Juan Shi; Qipeng Yuan; Ming Yang; Dongxin Lin
Journal:  Carcinogenesis       Date:  2013-06-08       Impact factor: 4.944

6.  Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.

Authors:  Tobias Zellweger; Kim Chi; Hideaki Miyake; Hans Adomat; Satoshi Kiyama; Kirsten Skov; Martin E Gleave
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

7.  Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis.

Authors:  P Wong; J Pineault; J Lakins; D Taillefer; J Léger; C Wang; M Tenniswood
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

Review 8.  Clusterin: physiologic and pathophysiologic considerations.

Authors:  M E Rosenberg; J Silkensen
Journal:  Int J Biochem Cell Biol       Date:  1995-07       Impact factor: 5.085

9.  Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.

Authors:  Laura V July; Eliana Beraldi; Alan So; Ladan Fazli; Kenneth Evans; John C English; Martin E Gleave
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

10.  Apolipoprotein J: structure and tissue distribution.

Authors:  H V de Silva; J A Harmony; W D Stuart; C M Gil; J Robbins
Journal:  Biochemistry       Date:  1990-06-05       Impact factor: 3.162

View more
  1 in total

1.  GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.

Authors:  Yung-Kuan Tsou; Kung-Hao Liang; Wey-Ran Lin; Hsien-Kun Chang; Chen-Kan Tseng; Chau-Ting Yeh
Journal:  Oncotarget       Date:  2017-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.